buspirone has been researched along with Epilepsy in 3 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To describe a case of an intellectually disabled patient who was diagnosed with autistic disorder (AD) and responded positively to buspirone, demonstrated by a reduction in target behaviors of self-injury, property destruction, and physical aggression." | 7.74 | Buspirone for autistic disorder in a woman with an intellectual disability. ( Brahm, NC; Brown, RC; Fast, GA, 2008) |
| "To describe a case of an intellectually disabled patient who was diagnosed with autistic disorder (AD) and responded positively to buspirone, demonstrated by a reduction in target behaviors of self-injury, property destruction, and physical aggression." | 3.74 | Buspirone for autistic disorder in a woman with an intellectual disability. ( Brahm, NC; Brown, RC; Fast, GA, 2008) |
| "Future research strategies for new drug treatments in epilepsy will probably take comorbidities into account." | 2.58 | Pharmacological treatment of anxiety disorders in adults with epilepsy. ( Mula, M, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mula, M | 1 |
| Brahm, NC | 1 |
| Fast, GA | 1 |
| Brown, RC | 1 |
| Grunze, H | 1 |
| Walden, J | 1 |
1 review available for buspirone and Epilepsy
| Article | Year |
|---|---|
Pharmacological treatment of anxiety disorders in adults with epilepsy.
Topics: Adult; Animals; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Epilepsy; Humans; Phobia, Social; | 2018 |
2 other studies available for buspirone and Epilepsy
| Article | Year |
|---|---|
Buspirone for autistic disorder in a woman with an intellectual disability.
Topics: Adult; Aggression; Anti-Anxiety Agents; Antipsychotic Agents; Autistic Disorder; Buspirone; Epilepsy | 2008 |
Reduction of the frequency of occurrence of low magnesium induced field potentials in the hippocampus slice preparation of guinea pigs: a good screening tool for calcium antagonistic effects of anticonvulsant and antipsychotic drugs.
Topics: Animals; Anticonvulsants; Antipsychotic Agents; Buspirone; Calcium Channel Blockers; Carbamazepine; | 1997 |